Taiwan FDA registration 5593b1bfd5c6347ed5f5d5137fceb1e2
Qixiang anti-B blood group reagent
TW: 啟翔抗B血型試劑
Taiwan·Dayuan Factory of Taifu Pharmaceutical Co., Ltd·Registered Apr 19, 2004 – Apr 19, 2009CancelledRegistration details
- Analysis ID
- 5593b1bfd5c6347ed5f5d5137fceb1e2
- Customs Code
- DHY00500110402
Company information
- Manufacturer
- Dayuan Factory of Taifu Pharmaceutical Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Qi Xiang Biotechnology Co., Ltd
Product details
- Intended Use
- Measurement type B hemopenter.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Import Information
- Domestic
Dates and status
- Registration Date
- Apr 19, 2004
- Expiry Date
- Apr 19, 2009
- Cancellation Date
- Nov 07, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Qixiang anti-B blood group reagent in Taiwan's medical device market through Pure Global AI's free database. is registered under number 5593b1bfd5c6347ed5f5d5137fceb1e2 and manufactured by Dayuan Factory of Taifu Pharmaceutical Co., Ltd. The authorized representative in Taiwan is Qi Xiang Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices